Atlas Trials

YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT07390565 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07390565
Sponsor
LI FENG
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
Extensive-stage Small Cell Lung Cancer (SCLC)
Start date
2026-02-17
Primary completion
2026-12-31
Enrollment
308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.